Search Results 1641-1650 of 16887 for monoclonal antibody

1. Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies - Mayo Clinic

   hepatitis B core antibody [anti-HBc] and absence of HBsAg) are eligible. Participants positive for hepatitis C (HCV) antibody are eligible only if polymerase ...

2. A Study to Compare Standard-Dose Combination Chemotherapy with High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Resistant Germ Cell Tumors - Mayo Clinic

   Hepatitis C antibody. No late relapse with completely surgically resectable disease; Patients with late relapses defined as relapse ≥ 2 years from the date ...

3. Mechanisms of Astrocyte Reactivity - Translational Neuroimmunology Laboratory - Mayo Clinic Research

   Focus areas include: Discovering the mechanisms underlying astrocyte reactivity induced by the pathogenic antibody present in patients with neuromyelitis optica ...

4. Infectious Diseases Clinical Trials - Mayo Clinic Research

   Phage, expressing melanoma cDNA express the proteins/peptides on their capsid are “recognized” by the immobilized antibodies are retained in ... Communities ...

5. Hematology - Clinical trials

   The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

6. Immunostains Laboratory - Division of Anatomic Pathology - Mayo Clinic

   The Immunostains lab performs immunohistochemistry (IHC), in-situ hybridization (ISH) and mass spectrometry-based proteomic (MS) clinical diagnosis tests.

7. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome - Mayo Clinic

   - Absent or low patient donor-specific antibodies (DSA); - Mean fluorescence intensity (MFI) of any anti-donor HLA antibody by solid phase immunoassay ...

8. A Study to Obtain Blood from Patients with Gammopathies - Mayo Clinic

   Any patient with monoclonal, biclonal or triclonal gammopathy. Exclusion Criteria: Patients with serious medical problems such as congestive heart failure ...

9. Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   ... antibody. Patients must be at least 90 days since an autologous stem cell transplant, if performed. 3.1.5 Patients must have measurable disease per IMWG ...

10. Lymphoma - Doctors and departments - Mayo Clinic

    Leif Bergsagel, M.D.. Internist; Oncologist. Phoenix, AZ. Areas of focus: Amyloidosis, Multiple myeloma, Waldenstrom macroglobulinemia, Monoclonal gammopathy of ...